Kobayashi, Y., Yuki, S., Kawamoto, Y., Sawada, K., Miyagishima, T., Ehira, N., Iwanaga, I., Okuda, H., Tateyama, M., Tsuji, Y., Hatanaka, K., Nakamura, M., Kudo, M., Fukushima, H., Tagaki, T., Hisai, H., Koike, M., Abe, R., Sakata, Y., & Komatsu, Y. (n.d.). 2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy. European journal of cancer, 51, S359–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000063